Archean Chemical Industries Limited has released its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors considered and approved the financial results during their meeting on July 30, 2026, with the results also subjected to a limited review by the statutory auditors. On a standalone basis, the company reported total income of ₹315.93 crore with profit before tax of ₹55.31 crore and profit after tax of ₹40.53 crore. Basic earnings per share (EPS) were ₹3.28, while diluted EPS were also ₹3.28. On a consolidated basis, total income reached ₹332.81 crore with profit before tax of ₹44.22 crore and profit after tax of ₹30.35 crore. Consolidated basic EPS was reported at ₹2.48, and diluted EPS at ₹2.48.
Archean Chemical Industries reported a 21.83% decline in standalone net profit to ₹40.53 crore in Q1 FY27, compared to ₹51.85 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this profit decline occurred despite the company achieving revenue growth during the same period. The consolidated net profit of ₹30.35 crore also declined from ₹40.19 crore in Q1 FY26, reflecting challenging profitability conditions. The company's consolidated profit after tax of ₹30.35 crore was lower than the standalone net profit of ₹40.53 crore, indicating that subsidiaries are in investment and scaling phases, incurring expenses that drag down the group's overall performance.
The company's standalone revenue from operations grew by 13.39% to ₹315.93 crore in Q1 FY27, up from ₹278.63 crore recorded in the same quarter of the previous financial year. As reported by Business Standard, this revenue growth indicates strong product demand in the marine chemicals segments and steady volume off-take in core marine chemicals operations. The standalone total income of ₹33,207.47 lakhs and consolidated total income of ₹33,280.52 lakhs for Q1 FY27 further demonstrates the company's revenue expansion trajectory despite facing profitability challenges.
Operating profit margin (OPM) declined to 20.56% in the June 2026 quarter from 26.71% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin compression contributed to the overall decline in profitability despite the company's revenue growth. The standalone profit before tax of ₹55.31 crore and consolidated profit before tax of ₹44.22 crore for Q1 FY27 reflect the impact of higher operating costs and raw material expenses that continue to affect profitability. The consolidated net profit decline of 24.48% YoY was weighed down by initial-stage subsidiary operating losses.
ICICI Securities has issued a buy rating on Archean Chemical Industries with a target price of ₹640 in its research report dated August 03, 2026. According to the latest report, Archean Chemical's Q1FY27 EBITDA shrank 13.9% YoY due to salts business challenges and higher logistics costs, but showed 53.9% quarter-on-quarter recovery with improved bromine volumes and prices. The brokerage notes that Acume Chemicals (bromine derivative) has achieved EBITDA break-even, and the company is guiding to exit FY27 with bromine production of 20-25kte annualised with blended bromine price of ₹300/kg. ICICI Securities has changed its valuation methodology to EV/EBITDA (16x FY28E EBITDA) and maintains a buy rating, citing the execution of Sicsem project as a key rerating catalyst.
